Evidence map›Paper›PMID 39968624›Full record

ReviewThe Plant journal : for cell and molecular biology2025

Genome editing, an opportunity to revive soybean cultivation in Europe.

Manon Monfort, Julia Buitink, Frank Roeber, Fabien Nogué

Abstract readReview
In one paragraph

Review in The Plant journal : for cell and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Epigenomics and Non-Coding RNAs in Soybean Adaptation to Abiotic Stresses.International journal of molecular sciences · 2025
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manon MonfortInstitut Jean-Pierre Bourgin, INRAE, AgroParisTech, Université Paris-Saclay, Versailles, 78000, France.
Julia BuitinkINRAE, Institut Agro, Univ Angers, IRHS, SFR QUASAV, Angers, F-49000, France.ORCID 0000-0002-1457-764X
Frank RoeberCorteva Agriscience Germany GmbH, Riedenburgerstr. 7, Munich, 81677, Germany.
Fabien NoguéInstitut Jean-Pierre Bourgin, INRAE, AgroParisTech, Université Paris-Saclay, Versailles, 78000, France.ORCID 0000-0003-0619-4638

Funding

Agence Nationale de la Recherche ANR-22-PSV-002Association Nationale de la Recherche et de la Technologie
6 · The paper itself

Abstract

Soybean (Glycine max Merr.) is the world's most important oilseed crop and its ability to fix atmospheric nitrogen makes it a cornerstone of sustainable agriculture. Despite its importance, Europe relies heavily on imports, leading to environmental and economic vulnerabilities. To address these challenges, the European Union has implemented policies to boost local soybean production, emphasizing sustainable practices and reduced dependency on imports. However, conventional breeding methods are time-consuming and may not keep pace with the rapid environmental and consumer habit changes. Genome-editing technologies, such as CRISPR-Cas, offer precise and efficient tools for developing soybean varieties tailored to European conditions. These technologies can enhance traits related to precocity, stress responses, yield and quality that are essential for adapting to climate change and promoting ecological sustainability. This review explores the integration of genome editing (GE) in soybean breeding, highlighting its potential in advancing the agroecological transition in Europe. By having a clear regulation and enhancing breeding efforts, GE can significantly contribute to developing resilient and sustainable soybean varieties, fostering a competitive and environmentally friendly European agriculture.

Indexed as

Gene EditingGenome, PlantGlycine maxCRISPR-Cas SystemsCrops, AgriculturalEuropePlant BreedingPlants, Genetically ModifiedagroecologyBreedingEuropegenome editingNew Genomic Techniquessoybean

Identifiers

PMID39968624
PMCPMC11836770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.